Viewing Study NCT01587027


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-03-05 @ 1:33 AM
Study NCT ID: NCT01587027
Status: COMPLETED
Last Update Posted: 2017-02-10
First Post: 2012-04-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety Evaluation of Aminophylline and Methazolamide
Sponsor: Poudre Valley Health System
Organization:

Study Overview

Official Title: The Safety Evaluation of Aminophylline and Methazolamide When Administered Orally Alone and in Combination to Healthy Volunteers
Status: COMPLETED
Status Verified Date: 2016-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.
Detailed Description: After successful completion of this safety trial, our goal will be to evaluate the safety of this combination in healthy individuals exposed to hypoxia and exercise. Subsequently, an efficacy study will clarify whether this drug combination improves physical and mental functions in human subjects under high altitude conditions.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: